Cannabis on prescription: Bundestag cancels cost coverage for cannabis flowers
- Approximately 65,000 cannabis patients in the statutory health insurance are affected by the removal
- Cannabis flowers: no more reimbursement from the insurance, but not prohibited, still available via private prescription
- New hurdle for prescription medicines (extract drops, sprays, capsules, oils, creams): a six-month therapy trial with an approved finished pharmaceutical product is now mandatory
The Bundestag and the Bundesrat had already decided on July 10, 2026, and today it officially comes into force: the GKV-Spargesetz. For legally insured cannabis patients, this is not a minor detail on the edge of a savings package, but a substantial cut in a form of therapy that has been considered relatively uncomplicated and accessible for years. Those who previously knew what a cannabis prescription actually required were familiar with the process: diagnosis, prescription, approval by the insurance company, redemption at the pharmacy. Exactly at this process, the new law intervenes, at least when it comes to cannabis flowers.
What the GKV-Spargesetz specifically changes
The law is part of a larger package aimed at relieving statutory health insurance funds by a total of 19 billion euros. Cannabis therapies are just one of many components, but one with a direct impact on a vulnerable patient group: chronically ill patients who are prescribed cannabis flowers, often after years of trying other treatments.
| Area | Until July 29, 2026 | From July 30, 2026 |
|---|---|---|
| Cannabis flowers | Reimbursement possible (with approval from the insurance fund) | No reimbursement from the insurance fund anymore, only private prescription |
| Extracts / prescription medicines | Reimbursement possible | Reimbursement only after 6 months of therapy with finished medicinal products |
| Finished medicinal products (Dronabinol, Nabilon) | Reimbursable | Still reimbursable |
Cannabis flowers: No insurance prescription anymore, but no ban
The most important single measure concerns cannabis flowers. They have been completely removed from the service catalog of the statutory health insurance (GKV). This means: A prescription for cannabis flowers is no longer available from now on, regardless of how long a patient has already been successfully treated with them. However, this does not mean that it is prohibited. Doctors can still prescribe cannabis flowers, but exclusively via a private prescription. Then the patient bears the full cost themselves.
For everyone wondering how a private prescription for cannabis flowers works in practice and what it costs, a closer look is worthwhile: The medical path to the prescription remains the same, only the invoice will no longer be sent to the health insurance company in the future.
What happens with extracts and finished medicinal products
It looks somewhat more nuanced with cannabis extracts and the approved finished medicinal products Dronabinol and Nabilon. These remain generally eligible for reimbursement, so the legislature has not made a complete cut here. However, a new hurdle has been added: Before a prescription medicine, such as extract drops, sprays, capsules, oils, or cannabis-based creams, can even be prescribed, a mandatory six-month therapy trial with an approved finished medicinal product is now required.
Practically speaking, this means that patients must first prove that an approved preparation such as Dronabinol or Nabilon has been tried for six months before the insurance company will cover a prescription medicine. During these first six months of therapy, the aforementioned prescription medicines (extract drops, sprays, capsules, oils, creams) are also excluded from reimbursement. Anyone starting a cannabis therapy fresh will now necessarily begin with a finished medicinal product and not with an individual prescription.
Who the new regulation affects and what happens next
Nach aktuellem Stand sind rund 65.000 Cannabis-Patient*innen in der gesetzlichen Krankenversicherung von der Neuregelung betroffen. Für sie stellt sich ab sofort die ganz praktische Frage: Wie Kostenübernahme Cannabis Krankenkasse überhaupt noch funktioniert, hängt jetzt entscheidend davon ab, welches Cannabis-Präparat verordnet wird. Bei Cannabisblüten lautet die Antwort ab heute schlicht: gar nicht mehr über die Kasse. Bei Extrakten und Fertigarzneimitteln lohnt sich dagegen weiterhin ein genauer Blick auf die neuen Voraussetzungen, bevor man sich vom behandelnden Arzt oder der behandelnden Ärztin ein Rezept ausstellen lässt.
Wer sich unsicher ist, ob im eigenen Fall übernimmt die Krankenkasse noch Kosten für Cannabis, sollte das am besten direkt mit der eigenen Kasse klären, idealerweise bevor ein neues Rezept ausgestellt wird, um teure Überraschungen zu vermeiden. Wer ohnehin schon länger mit dem Gedanken spielt, sich unabhängig von der Kassenlage zu informieren, findet in unserem Vergleich der Telekliniken einen Überblick über Anbieter, Preise und Abläufe abseits der klassischen Arztpraxis, ebenso lohnt ein Blick in unseren
Privatrezept als Alternative: Was Patient*innen jetzt einplanen sollten
For many of the 65,000 affected patients, switching to a private prescription is likely to be the most obvious option to continue their accustomed therapy with cannabis flowers. This means specifically: the doctor’s visit, whether in the practice or online via a teleclinic, remains necessary, only now the patient themselves bears the costs for the prescription and medication. Those who want to compare prices from different providers before deciding on a private prescription can also find coupon codes for cannabis prescriptions, which can at least partially offset the new out-of-pocket costs.
FAQ: Cannabis on prescription under the GKV-Spargel Act
Zusammenfassung
With the implementation of the GKV-Spargesetz on July 30, 2026, the reimbursement of cannabis flowers by health insurance for about 65,000 legally insured cannabis patients will come to an end. This is not a ban: cannabis flowers remain available via private prescriptions, but at the patient’s own expense. For extracts and approved finished medicinal products, reimbursement is generally possible, although only after a six-month therapy trial with an approved preparation. Those affected should inform themselves thoroughly before the next prescription, can the prescription be billed through the health insurance or is switching to a private prescription now necessary. Our Guide to the Cannabis Prescription continues to explain step by step how diagnosis, prescription, and fulfillment in the pharmacy proceed, regardless of whether the insurance or the patient ultimately pays.
Cannabis Drinks: Smoothies, Tea, Golden Milk & Recipes
Cannabis Grillen: BBQ, Marinaden & Rezepte für den Sommer
Infused Kitchen: Cannabis recipes for baking, cooking, grilling & drinks
Social Media Ads: More Sales Through Targeted Online Marketing
Career start after studies: What recruiters are really looking for
Internship at Top Companies: Opportunities, Compensation and the Direct Path to a Career
